Apotea AB (publ) (STO:APOTEA)

Market Cap	6.29B -16.7%
Revenue (ttm)	7.21B +10.1%
Net Income	228.70M +6.4%
EPS	2.20 +5.1%
Shares Out	104.07M
PE Ratio	27.52
Forward PE	24.00
Dividend	0.60 (0.99%)
Ex-Dividend Date	n/a

Volume	515,817
Average Volume	688,969
Open	60.33
Previous Close	60.33
Day's Range	59.00 - 60.98
52-Week Range	58.62 - 122.00
Beta	n/a
RSI	26.49
Earnings Date	Feb 4, 2026

About Apotea AB

Apotea AB (publ) operates an online pharmacy in Sweden. The company offers products in the areas of allergy, face, child and parent, bite and sting, preparedness, animal, fever and aches, cold, home and household, aid, hair removal and shaving, hair care, hands and feet, intimate, and dietary supplements. It also provides products in the categories of body care, stomach and intestine, food and drink, mouth and teeth, premium, trip, sex and lust, stop smoking, makeup, sun protection, wounds and injuries, sleep and sleep problems, training, weigh...

• Industry: Pharmaceutical Retailers
• Sector: Healthcare
• Founded: 2011
• Employees: 724
• Stock Exchange: Nasdaq Stockholm
• Ticker Symbol: APOTEA

Financial Performance

In 2025, Apotea AB's revenue was 7.21 billion, an increase of 10.06% compared to the previous year's 6.55 billion. Earnings were 228.70 million, an increase of 6.42%.